title: Conductor of regulatory cells: does vitamin D restore the shifted balance of the distinct regulatory cell types in undifferentiated connective tissue disease?
authors.forename: Sándor
authors.initials: S
authors.lastname: Baráth
authors.forename: Gábor
authors.initials: G
authors.lastname: Nagy
authors.forename: Eva
authors.initials: E
authors.lastname: Zöld
authors.forename: István
authors.initials: I
authors.lastname: Csípő
authors.forename: Edit
authors.initials: E
authors.lastname: Gyimesi
authors.forename: Margit
authors.initials: M
authors.lastname: Zeher
authors.forename: Edit
authors.initials: E
authors.lastname: Bodolay
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D017252:CD3 Complex / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D019002:CD56 Antigen / Q000378:metabolism; D003240:Connective Tissue Diseases / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D018655:Lymphocyte Count; D008875:Middle Aged; D014808:Vitamin D Deficiency / Q000188:drug therapy
chemical_list: D017252:CD3 Complex; D019002:CD56 Antigen; D006887:Hydroxycholecalciferols; C008088:alfacalcidol